| Name | Benchmark Holdings |
|---|---|
| Epic | BMK |
| Isin | GB00BGHPT808 |
| Index | AIM50 AIM350 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 38.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £281.12 | Debt ratio | n/a |
| Shares in issue | 739.75 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -3.64 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -4.6 | 52-week high / low | 34.00p / 48.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Benchmark Holdings |
|---|---|
| Address | Highdown House, Yeoman Way, Worthing, West Sussex, United Kingdom, BN99 3HH |
| Telephone | |
| Website | http://www.bmkholdings.com |
| Director | Position |
|---|---|
| Mr Trond Williksen | CEO |
| Mrs Septima Maguire | CFO |
| Mr Peter George | Chairman |
| Mr Jonathan Esfandi | Non-Executive Director |
| Mr Yngve Myhre | Non-Executive Director |
| Mr Torgeir Svae | Non-Executive Director |
| Mr Marie Danielsson | Non-Executive Director |
| Mr Kristian Eikre | Non-Executive Director |
| Ms Jennifer Haddouk | Company Secretary |
| Assets £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Reporting date | 30/09/22 | 30/09/21 | 30/09/20 |
| Intangible asssets and goodwill | 245.26 | 229.04 | 247 |
| Investments and other non-current assets | 0.01 | 0.01 | 0.02 |
| Total non-current assets | 378.2 | 357.96 | 343.29 |
| Inventory / work in progress | 29.81 | 20.95 | 18.93 |
| Trade and other receivables | 56.38 | 46.5 | 39.37 |
| Cash and equivalents | 36.4 | 39.46 | 71.61 |
| Other current assets and asset held for resale | 25.78 | 17.12 | 15.85 |
| Total of all assets | 526.57 | 481.99 | 489.04 |
| Liabilities £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Short term liabilities | 73.26 | 63.52 | 55.37 |
| Long term liabilities | 130.03 | 138.87 | 138.22 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 203.29 | 202.39 | 193.59 |
| Net assets £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Net assets | 323.29 | 279.6 | 295.44 |
| Equity £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Share capital | 0.7 | 0.67 | 0.67 |
| Minority interests | 9.89 | 7.88 | 6.31 |
| Retained earnings | 77.7 | 30.46 | -142.17 |
| Share premium account | 420.82 | 400.68 | n/a |
| Total equity | 323.29 | 279.6 | 295.44 |
| Income £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -7.86 | -5.38 | -11.02 |
| Pre-tax profit | -23.18 | -9.18 | -22.57 |